France’s medical marijuana pilot program is underway. It’s missing only one thing: Marijuana.
Aurora’s Danish subsidiary, Aurora Nordic, is producing the dried flower. Vaporizers for the dried flower are being administered by Storz & Bickel, a subsidiary of Canada’s Canopy Growth. Edmonton, Alberta-based Aurora Cannabis along with Australia-based Little Green Pharma, Israel-based Panaxia, and Canada-based Tilray are also providing products. Aurora’s European distribution hub in Berlin is being utilized to transport it to France. Medical marijuana is being supplied at the companies’ cost — neither the government nor patients will have to pay for it.
“The first prescriptions of dried medical cannabis as part of the French pilot program are a significant step toward providing access to patients and will support the destigmatization of medical cannabis in France,” Aurora CEO Miguel Martin said in a statement.
Many European countries are experimenting with the distribution of medical marijuana to varying degrees of success. To cite one example, Denmark’s program experienced strong patient uptake but within two years patient access had fallen to fewer than 500 people – about half the program’s peak. Experts have warned it could be a long time before Europe’s already hypercompetitive regulated medical marijuana industry sees substantial revenue opportunities.